Senseonics Holdings Inc (NYSEAMERICAN:SENS) major shareholder Peter J. Barris sold 139,645 shares of the firm’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) opened at $2.60 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics Holdings Inc has a 1-year low of $1.26 and a 1-year high of $3.67.

Senseonics (NYSEAMERICAN:SENS) last issued its earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.13). Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The firm had revenue of $2.10 million for the quarter, compared to analysts’ expectations of $1.51 million. The company’s revenue for the quarter was up 425.0% on a year-over-year basis. research analysts predict that Senseonics Holdings Inc will post -0.54 earnings per share for the current year.

Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Senseonics from a “sell” rating to a “hold” rating in a report on Tuesday, August 15th. Canaccord Genuity restated a “buy” rating on shares of Senseonics in a report on Thursday, September 28th.

A number of institutional investors and hedge funds have recently modified their holdings of SENS. Raymond James Financial Services Advisors Inc. boosted its holdings in Senseonics by 221.4% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock worth $474,000 after buying an additional 181,562 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in Senseonics during the second quarter worth about $276,000. LMR Partners LLP bought a new position in Senseonics during the second quarter worth about $177,000. Susquehanna International Group LLP bought a new position in Senseonics during the second quarter worth about $155,000. Finally, Renaissance Technologies LLC bought a new position in Senseonics during the first quarter worth about $111,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at

Senseonics Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.